MADRID, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Neinor Homes („Neinor“) hat das Geschäftsjahr 2025 mit starken operativen und finanziellen Ergebnissen abgeschlossen. Im Geschäftsjahr 2025 – ohne [...] Read more »
Neinor enregistre un bénéfice net de 122 millions d’euros pour l’exercice 2025 après avoir conclu la plus grande opération de fusion-acquisition dans le secteur immobilier résidentiel espagnol ces dix dernières années
MADRID, 27 févr. 2026 (GLOBE NEWSWIRE) -- Neinor Homes (« Neinor ») a clôturé l’exercice 2025 en affichant des résultats d’exploitation et financiers exemplaires. Au cours de [...] Read more »
Neinor registra lucro líquido de € 122 milhões no AF25 após executar o maior M&A em residencial espanhol da última década
MADRI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- A Neinor Homes (“Neinor”) encerrou o AF25 com destaques nos resultados operacionais e financeiros. Durante o AF25, mas excluindo o impacto da aquisição de [...] Read more »
Neinor records €122mn FY25 Net Income after executing largest M&A in Spanish Residential of the last decade
MADRID, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Neinor Homes (“Neinor”) closed FY25 with standout operational and financial results. During FY25 and excluding the impact from acquiring a 79.2% stake in AEDAS, Neinor [...] Read more »
BTCS Reports Record Revenue for the Third Quarter 2025
Revenue Increases 568% Year–over–Year and 78% Sequentially to $4.94 Million
Q3 2025 Net Income Reaches $65.59 Million Driven by Ethereum Accumulation
Read more »
في نتائجها عن الفترة المنتهية في 30 سبتمبر 2025 استثمار القابضة تسجل ارتفاعاً في الإيرادات بنسبة 66% إلى 4.9 مليار ريال قطري وصافي الأرباح بنسبة 99% إلى 703 مليون ريال قطري
استمرار التوسع الدولي كمحرك رئيسي [...] Read more »
Estithmar Holding Reports 66% Revenue Growth to QAR 4.9 Bn and 99% Increase in Net Profit to QAR 703 Mn for the Nine Months Ended September 30, 2025
- Continued International Expansion Drives Sustained Growth
- All Key [...] Read more »
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
- FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density [...] Read more »
Swvl Grows 12.4% Quarter on Quarter in IFRS Revenue, 47% Quarter on Quarter Growth in Revenue in Constant Currency, and Achieves $0.8 Million in Net Profit in Q1 2025
Revenue growth of 12.4%, and 47% in constant currency for Q1 2025 over Q1 2024
Achieved $0.8 million in Net Profit in Q1 2025
Dollar pegged revenue increased [...] Read more »
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for [...] Read more »